ACM
EW icon

Aquatic Capital Management’s Edwards Lifesciences EW Stock Holding History

Aquatic Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,127
Closed -$1.41M – 1509
2025
Q3 		$1.41M Sell
18,127
-289,338
-94% -$22.6M 0.03% 576
2025
Q2 		$24M Buy
307,465
+236,437
+333% +$17.6M 0.49% 46
2025
Q1 		$5.15M Buy
+71,028
New +$5.08M 0.13% 207
2024
Q1 		– Sell
-373,000
Closed -$28.4M – 1343
2023
Q4 		$28.4M Buy
373,000
+273,700
+276% +$19M 0.73% 27
2023
Q3 		$6.88M Buy
+99,300
New +$7.98M 0.29% 90
2023
Q1 		– Sell
-60,200
Closed -$4.49M – 1395
2022
Q4 		$4.49M Buy
60,200
+38,800
+181% +$2.99M 0.33% 71
2022
Q3 		$1.77M Buy
+21,400
New +$2.06M 0.17% 169

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aquatic Capital Management's EW Position: Q4 2025 in Review

Aquatic Capital Management sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 18,127 shares — an estimated $1.41M sold.

Aquatic Capital Management first reported a position in EW in Q3 2022 and held it in 7 quarters. The position peaked at $28.4M in Q4 2023. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Aquatic Capital Management reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 18,127 Edwards Lifesciences shares in Q4 2025, an estimated $1.41M.
  • Aquatic Capital Management first reported a position in Edwards Lifesciences in Q3 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Edwards Lifesciences position peaked at $28.4M in Q4 2023.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.